CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 97 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $36 | -100.0% | 24,136 | -54.0% | 0.00% | -82.6% |
| Q4 2021 | $227,000 | +146.7% | 52,434 | +273.2% | 0.02% | +130.0% |
| Q4 2020 | $92,000 | +5.7% | 14,051 | +7.5% | 0.01% | -33.3% |
| Q3 2020 | $87,000 | -72.5% | 13,065 | +17.5% | 0.02% | -11.8% |
| Q1 2018 | $316,000 | +41.7% | 11,123 | -9.5% | 0.02% | +54.5% |
| Q3 2017 | $223,000 | – | 12,291 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 3,559,722 | $23,672,000 | 1.29% |
| Congress Park Capital LLC | 78,561 | $522,000 | 0.32% |
| Exane Asset Management | 63,820 | $424,403,000 | 0.28% |
| Perceptive Advisors | 2,577,043 | $17,137,000 | 0.25% |
| RTW INVESTMENTS, LP | 1,526,003 | $10,148,000 | 0.24% |
| Jackson Creek Investment Advisors LLC | 80,504 | $535,000 | 0.24% |
| HARBOURVEST PARTNERS LLC | 79,193 | $527,000 | 0.20% |
| TANG CAPITAL MANAGEMENT LLC | 112,880 | $751,000 | 0.14% |
| Virtus ETF Advisers LLC | 38,721 | $257,000 | 0.14% |
| GLOBEFLEX CAPITAL L P | 69,435 | $462,000 | 0.12% |